Downregulation of NOS3, NOTCH3, MYH11, MYL9, and TAGLN may implicate pericyte and vascular smooth muscle cell dysfunction and alterations to the blood-brain barrier in ALS-Ox patients64–66 (Fig. S10). This evidence concerns the gene NOS3 and amyotrophic lateral sclerosis.